News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Introduces New Protexis™ Latex Blue With Neu-Thera® Surgical Gloves
10/31/2011

DUBLIN, Ohio, Oct. 31, 2011 /PRNewswire/ — Cardinal Health today announced the launch of its new Protexis™ Latex Blue with Neu-Thera® sterile latex powder-free surgical gloves with emollient coating.

(Photo: http://photos.prnewswire.com/prnh/20111031/CL95444)

The newest addition to the Protexis™ portfolio of powder-free surgical gloves from Cardinal Health, these gloves are made from natural rubber latex and contain 50 micrograms or less of total water extractable protein per square decimeter. Their distinct blue color supports double-gloving initiatives, because the blue base layer provides contrast against a light-colored top glove, helping alert wearers to potentially dangerous breaches or perforations.  

Cardinal Health now offers blue underglove solutions in both powder-free latex and synthetic polyisoprene. Clinicians can select the glove type with the barrier protection, comfort, fit and indication properties they need when double-gloving.

Protexis™ Latex Blue with Neu-Thera® surgical gloves also include the company's exclusive Neu-Thera® emollient coating which aids in damp and dry donning. The formulation of the Neu-Thera® emollient coating promotes skin moisturization and supports hand hygiene compliance.

"Cardinal Health is dedicated to providing the innovative products clinicians need for protection from perforations and sharps injuries," said Lisa Ashby, president of Category Management at Cardinal Health. "And our addition of the Protexis™ Latex Blue with Neu-Thera® surgical gloves to our new Protexis™ powder-free surgical glove portfolio marks another step toward Cardinal Health providing a robust portfolio that our customers rely upon so they can perform confidently."

The recently introduced Protexis™ brand is the new brand name of the powder-free portfolio of surgical gloves from Cardinal Health, which includes both new and existing Cardinal Health surgical gloves. The new, advanced solutions - Protexis™ Latex Hydrogel and Protexis™ Latex Blue with Neu-Thera® - join gloves transitioning from  already-existing Duraprene™, Esteem® and Protegrity® brands.

The new Protexis™ naming system is simple, straightforward and easy-to-understand. Its architecture clearly communicates the material from which the gloves are made as well as their primary features and attributes.  

All Protexis™ surgical gloves are made using an exclusive hand mold with an independent thumb that allows for an anatomical fit and more natural movement in the fingers, thumb and palm. Forming a reliable barrier from fingertips to forearm, the gloves also have roll-down-resistant cuffs.

To learn more about the new Protexis™ Latex Blue with Neu-Thera® surgical gloves or the new Protexis™ brand, contact Linda McNeilly, director of marketing and product management for surgical gloves at Cardinal Health, at 1-847-887-2027 or linda.mcneilly@cardinalhealth.com.


About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #19 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.

SOURCE: Cardinal Health

More Company News
11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

11/05/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on...

11/01/2024

Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating earnings were $568 million; GAAP...

View all company news »